CLDX
Price
$22.08
Change
-$0.30 (-1.34%)
Updated
Aug 29 closing price
Capitalization
1.47B
67 days until earnings call
GPCR
Price
$19.30
Change
+$0.16 (+0.84%)
Updated
Aug 29 closing price
Capitalization
1.11B
74 days until earnings call
Interact to see
Advertisement

CLDX vs GPCR

Header iconCLDX vs GPCR Comparison
Open Charts CLDX vs GPCRBanner chart's image
Celldex Therapeutics
Price$22.08
Change-$0.30 (-1.34%)
Volume$1.33M
Capitalization1.47B
Structure Therapeutics
Price$19.30
Change+$0.16 (+0.84%)
Volume$514.64K
Capitalization1.11B
CLDX vs GPCR Comparison Chart in %
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. GPCR commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (CLDX: $22.08 vs. GPCR: $19.30)
Brand notoriety: CLDX and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 111% vs. GPCR: 68%
Market capitalization -- CLDX: $1.47B vs. GPCR: $1.11B
CLDX [@Biotechnology] is valued at $1.47B. GPCR’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 3 TA indicator(s) are bullish while GPCR’s TA Score has 6 bullish TA indicator(s).

  • CLDX’s TA Score: 3 bullish, 6 bearish.
  • GPCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -1.69% price change this week, while GPCR (@Biotechnology) price change was -1.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 05, 2025.

GPCR is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.47B) has a higher market cap than GPCR($1.11B). CLDX YTD gains are higher at: -12.624 vs. GPCR (-28.835). GPCR has higher annual earnings (EBITDA): -218.56M vs. CLDX (-231.4M). GPCR has more cash in the bank: 786M vs. CLDX (630M). CLDX has less debt than GPCR: CLDX (3.03M) vs GPCR (7.68M). CLDX has higher revenues than GPCR: CLDX (5.79M) vs GPCR (0).
CLDXGPCRCLDX / GPCR
Capitalization1.47B1.11B132%
EBITDA-231.4M-218.56M106%
Gain YTD-12.624-28.83544%
P/E RatioN/AN/A-
Revenue5.79M0-
Total Cash630M786M80%
Total Debt3.03M7.68M39%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXGPCR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHCX87.01N/A
N/A
Rydex Health Care C
EGOAX20.19N/A
N/A
Allspring Large Cap Core A
FMCVX26.55N/A
N/A
Franklin Mutual Small-Mid Cap Val R6
BMSRX15.21N/A
N/A
MFS Blended Research Mid Cap Eq R1
JDNNX78.24N/A
N/A
Janus Henderson Growth And Income N

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with CRNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.34%
CRNX - CLDX
51%
Loosely correlated
+1.11%
IDYA - CLDX
50%
Loosely correlated
-1.52%
BEAM - CLDX
50%
Loosely correlated
-2.91%
RVMD - CLDX
50%
Loosely correlated
-0.93%
ARCT - CLDX
50%
Loosely correlated
-1.68%
More